| Preventing and treating heart complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy |
| Preventing bleeding in people with congenital bleeding disorders during and after surgery |
| Preventing cryptococcal disease in HIV-positive people |
| Preventing death from blood clots, the formation of blood clots and blood clots in the lungs in people who have had physical trauma |
| Preventing dementia: do vitamin and mineral supplements have a role? |
| Preventing eating disorders in children and adolescents |
| Preventing misconduct and promoting integrity in research and publication |
| Preventing or reducing partner violence against women during pregnancy |
| Preventing pain after brain surgery |
| Preventing type 2 diabetes in adults with mental health conditions in low- and middle-income countries |
| Preventing venous thromboembolism in women during pregnancy, childbirth and after birth |
| Prevention and treatment interventions for nausea and vomiting during initiation of chronic opioid therapy |
| Prevention and treatment of fungal infections with nystatin in severely immunodepressed patients |
| Prevention and treatment of postpartum hypertension |
| Prevention and treatment regimens for recurrent corneal erosion (corneal epithelial surface breakdown) |
| Prevention of blood clots in adults diagnosed with acute lymphoblastic leukaemia and treated with asparaginase-based chemotherapy |
| Prevention of blood clots in non-hospitalised cancer patients receiving chemotherapy |
| Prevention of blood clots in patients undergoing cardiac or thoracic surgery |
| Prevention of dementia and decline in cognition by using multi-domain interventions |
| Prevention of diarrhoea in children with HIV infection or who were born to an HIV-infected mother |
| Prevention of fungal infections in cancer patients with amphotericin B or fluconazole |
| Prevention of fungal infections in patients with cancer with amphotericin B |
| Prevention of fungal infections in patients with cancer with antifungal drugs |
| Prevention of infection in aortic or aortoiliac peripheral arterial reconstruction |
| Prevention of infection in peripheral arterial reconstruction of the lower limb |
| Prevention of infection with surgery for peripheral arterial reconstruction |
| Prevention of occlusion of small veins in the liver after blood-forming stem cell transplantation |
| Prevention of poor blood flow in the veins in a standing worker population |
| Prevention of rebleeding from enlarged veins in the food pipe (oesophagus) resulting from advanced liver disease |
| Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant |
| Prevention of self-harm and suicide in young people up to the age of 25 in education settings |
| Prevention of suicide in university and other post-secondary educational settings |
| Prevention of thrombosis in children with cancer and tunnelled CVCs |
| Prevention of transmission of cytomegalovirus from mother to fetus during pregnancy |
| Preventive staff-support interventions for health workers |
| Preventive treatments for repeated episodes of cellulitis and erysipelas |
| Preventive use of implantable heart defibrillators in people with poor heart function |
| Preventive use of steroids in children after open heart surgery. |
| Primaquine for preventing relapses in people with Plasmodium vivax malaria |
| Primaquine or tafenoquine for preventing malaria in people travelling to or living in endemic areas |
| Primaquine to cure people with malaria: comparing dosing schedules |
| Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction |
| Primary care based clinics for asthma |
| Primary care professionals providing non-urgent care in hospital emergency departments |
| Primary care versus specialty care management of opioid use disorder |
| Primary closure (immediate stitches) versus delayed closure (delayed stitches) or no closure (no stitches) for traumatic wounds due to mammalian bite |
| Primary cryotherapy for localised or locally advanced prostate cancer |
| Primary immunosuppression following heart transplantation |
| Primary prevention for alcohol misuse in young people |
| Primary prevention interventions for reducing school violence |
| Primary prevention of suicide and suicidal behaviour for adolescents in school settings |
| Primary-level and community worker interventions for the prevention of mental disorders and the promotion of well-being in low- and middle-income countries |
| Printed educational materials for healthcare professional practice and patient health |
| PRO 140 for treatment of people with HIV infection |
| Probable that silver-containing dressings and creams do not prevent wound infection or promote healing |
| Probiotic agents for the treatment of diarrhoea-predominant irritable bowel syndrome |
| Probiotic bacteria improve cholesterol levels |
| Probiotics ('healthy bacteria') for preventing acute middle ear infection in children |
| Probiotics as adjunctive therapy for eradication of Helicobacter pylori infection |
| Probiotics as an added treatment for gestational diabetes to improve mother and baby outcomes |
| Probiotics for fibromyalgia |
| Probiotics for maintenance of remission in Crohn's disease |
| Probiotics for maintenance of remission in ulcerative colitis |
| Probiotics for people with cystic fibrosis |
| Probiotics for people with hepatic encephalopathy |
| Probiotics for persistent diarrhoea in children |
| Probiotics for preventing preterm labour |
| Probiotics for preventing urinary tract infections in adults and children |
| Probiotics for preventing urinary tract infections in people with bladder dysfunction after a nervous system injury |
| Probiotics for preventing ventilator-associated pneumonia |
| Probiotics for prevention of necrotising enterocolitis in very preterm or very low birth weight infants |
| Probiotics for the management of functional abdominal pain disorders in children |
| Probiotics for the prevention of antibiotic-associated diarrhea in children |
| Probiotics for the prevention or treatment of hyperbilirubinaemia in late preterm and term neonates |
| Probiotics for the treatment of active Crohn's disease |
| Probiotics for the treatment of active ulcerative colitis |
| Probiotics for the treatment of bacterial vaginosis |
| Probiotics for the treatment of irritable bowel syndrome in children |
| Probiotics for treating eczema |
| Probiotics for treatment of chronic constipation in children |
| Probiotics for treatment of Clostridium difficile
-associated colitis in adults |
| Probiotics for vulvovaginal candidiasis in non-pregnant women |
| Probiotics in infants for prevention of allergic disease and food hypersensitivity |
| Probiotics to prevent gestational diabetes mellitus |
| Probiotics to prevent infantile colic |
| Problem solving skills for schizophrenia |
| Problem solving treatment (PST) for emotional problems in primary care |
| Probucol for type 2 diabetes mellitus |
| Procaine is a controversial substance that has been used for "antiageing" effects including cognitive improvement for more than 50 years |
| Procalcitonin evaluation for reducing mortality in adults with sepsis |
| Procalcitonin for the diagnosis of sepsis in neonates: a diagnostic test accuracy review |
| Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children |
| Procalcitonin, C-reactive protein, and presepsin for the diagnosis of sepsis in adults and children |
| Procedures for retreatment of failed root canal therapy |
| Processed versus fresh frozen bone for repairing the bone in revision hip surgery |
| Producing Evidence: Goal 1 of Strategy to 2020 |
| Prof Jimmy Volmink recognised with honorary doctorate for ‘individuals of exceptional distinction’ |
| Prof Tracey Howe appears in Decade of Healthy Ageing ‘Leaders Voices’ video alongside WHO and UN leadership |
| Professional interventions for general practitioners (GPs) on the management of musculoskeletal conditions |
| Professional interventions to implement guidelines to prevent hazardous alcohol consumption by patients in primary care settings |
| Professionally applied fluoride paint-on solutions for the control of dental caries in children and adolescents |
| Professionally-applied chemically-induced whitening of teeth in adults |
| Professions allied to medicine, such as nurses, midwives and dietiticians, can effectively incorporate clinical guidelines to improve patient care |
| Professor Julian Higgins receives award from the Society for Research Synthesis Methodology |
| Progabide add-on for refractory epilepsy |
| Progestagens and anti-progestagens for pain associated with endometriosis |
| Progesterone for premenstrual syndrome |
| Progesterone for preventing pre-eclampsia and its complications |
| Progesterone for traumatic brain injury |
| Progesterone receptor modulators for endometriosis |
| Progestin intrauterine devices versus copper intrauterine devices for emergency contraception |
| Progestin-only pills for contraception |
| Progestogen for preventing miscarriage |
| Progestogen for treating threatened miscarriage |
| Progestogen only versus combined oral contraceptive pills for fibroid related heavy menstrual bleeding |
| Progestogens for hot flushes |
| Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy) |
| Progestogens versus gonadotrophin-releasing hormone (GnRH) agonists, GnRH antagonists and other progestogens for women undergoing assisted reproductive technology (ART) |
| Progestogens with or without oestrogen for irregular menstrual bleeding |
| Prognosis of adults with idiopathic pulmonary fibrosis without treatment or without effective therapies |
| Prognostic accuracy of imaging findings for predicting morbidity and mortality in patients with COVID-19 |
| Prognostic factors for predicting progression of open angle glaucoma in adults |
| Prognostic factors for return to work following knee arthroplasty |
| Prognostic factors for return to work in breast cancer survivors |
| Prognostic factors predicting an unprovoked seizure recurrence in children and adults following a first unprovoked seizure |
| Prognostic models for colorectal cancer incidence and mortality in patients with inflammatory bowel disease |
| Prognostic models for predicting recurrence and survival in women with endometrial cancer |
| Prognostic models for predicting the severity and mortality in people with acute pancreatitis |
| Prognostic models for radiation-induced complications after radiotherapy in head and neck cancer patients |
| Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer |
| Programmes based in primary schools designed to help prevent tooth decay by changing children's behaviour |
| Programmes, policies and work practices that reduce aggression by patients towards healthcare workers |
| Programs for preventing pregnancy and disease through better condom use |
| Programs for preventing pregnancy and disease through using two methods of contraception |
| Programs to improve birth control use by postpartum women |
| Progressive resistance strength training for improving physical function in older adults |
| Progressive resistive exercise interventions for adults living with HIV/AIDS |
| Prolonged antibiotics for purulent bronchiectasis in children and adults |
| Prolonged lung inflation for resuscitation of babies at birth |
| Prolonged storage of packed red blood cells (storage of 21 days or more) in comparison with fresh cells on recipients of blood transfusion |
| Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants |
| Prolotherapy injections for chronic low-back pain |
| Promoting cough in critically-ill adults and children to enable removal of the breathing tube (extubation) and breathing without the machine (weaning) |
| Promoting evidence-based health care in Africa |
| Promoting patient uptake and adherence in cardiac rehabilitation |
| Promoting the use of information and communication technologies (ICTs) by health care professionals |
| Prompts to encourage appointment attendance for people with serious mental illness |
| Prone (face-down) position for mechanical ventilation of adults with acute respiratory failure |
| Prone position for management of respiratory failure in non-intubated adults |
| Prophylactic (preventive) chemotherapy for hydatidiform mole (molar pregnancy) to prevent cancerous growth later |
| Prophylactic administration of colony-stimulating factors reduces hospital stay and risk of infections in children with acute lymphoblastic leukaemia |
| Prophylactic anastomotic drainage for colorectal surgery |
| Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants |
| Prophylactic antibiotic therapy for chronic bronchitis |
| Prophylactic antibiotic therapy for people with chronic obstructive lung disease (COPD) |
| Prophylactic antibiotics for infection control in patients with penetrating chest trauma |
| Prophylactic antibiotics for inhibiting preterm labour in women whose membranes are still intact |
| Prophylactic antibiotics for manual removal of retained placenta in vaginal birth |
| Prophylactic antibiotics for people with COPD |
| Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer |
| Prophylactic antibiotics for preventing recurrent symptomatic episodes of acute diverticulitis |
| Prophylactic antibiotics for transcervical intrauterine procedures |
| Prophylactic antibiotics for tube thoracostomy |
| Prophylactic antibiotics for uterine evacuation procedures to treat miscarriage |
| Prophylactic antibiotics or G(M)-CSF for the prevention of infections in cancer patients undergoing chemotherapy |
| Prophylactic antibiotics to prevent infection after cervical excision |
| Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery catheters |
| Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters |
| Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters |
| Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants |
| Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies |
| Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting |
| Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting |
| Prophylactic arterial embolization in patients with bleeding peptic ulcers following endoscopic control of bleeding |
| Prophylactic blood thinners for the prevention of death and venous thromboembolism in COVID-19 outpatients |
| Prophylactic caffeine to prevent postoperative apnoea following general anaesthesia in preterm infants |
| Prophylactic cholecystectomy should be offered to patients whose gallbladders remain in-situ after endoscopic sphincterotomy and common bile duct clearance |
| Prophylactic colony-stimulating factors to prevent infectious complications in patients with breast cancer undergoing chemotherapy |
| Prophylactic corticosteroids for preterm birth |
| Prophylactic cranial irradiation for extensive-stage small cell lung cancer |
| Prophylactic cranial irradiation for patients with limited-stage small cell lung cancer |
| Prophylactic cranial irradiation improves survival rate of patients with small-cell lung cancer in complete remission |
| Prophylactic cyclo-oxygenase inhibitor drugs to prevent morbidity and mortality in preterm infants |
| Prophylactic cyclo-oxygenase inhibitor drugs to prevent morbidity and mortality in preterm infants |
| Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation |
| Prophylactic drug management for febrile seizures in children |
| Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour |
| Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period |
| Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants |
| Prophylactic intravenous preloading for regional analgesia in labour |
| Prophylactic lidocaine for myocardial infarction |
| Prophylactic manual rotation for fetal malposition to reduce operative delivery and reduce complications for mothers and babies |
| Prophylactic methylxanthine for prevention of apnoea in preterm infants |
| Prophylactic methylxanthines for extubation in preterm infants |
| Prophylactic non-steroidal anti-inflammatory drugs (NSAIDs) for the prevention of macular oedema after cataract surgery |
| Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies |
| Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants |
| Prophylactic paracetamol for the prevention of fever in children receiving vaccination as part of a standard childhood immunization schedule |
| Prophylactic phototherapy for preventing jaundice in preterm very low birth weight infants |
| Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants |
| Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants |
| Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants |
| Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters |
| Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants |
| Prophylactic treatment with monoclonal antibodies targeting the CGRP pathway for migraine prevention |
| Prophylactic use of inotropic agents for the prevention of low cardiac output syndrome and mortality in adults undergoing cardiac surgery |
| Prophylactic versus selective antibiotics for term newborn infants of mothers with risk factors for neonatal infection |
| Prophylactic versus selective blood transfusion for sickle cell anaemia during pregnancy |
| Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants |
| Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour |
| Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates |
| Prophylactic vitamin K for vitamin K deficiency bleeding in neonates |
| Prophylaxis for stress-related gastrointestinal bleeding |
| Prophylaxis for venous thromboembolism during asparaginase therapy in patients treated for acute lymphoblastic leukemia |
| Prophylaxis of leptospirosis may be achieved by administration of doxycycline to soldiers training in endemic areas with a high risk of exposure to leptospirosis. Whether these findings apply to other scenarios or not remains to be proven |
| Prophylaxis with Immunoglobulin G (IgG), anti CMV vaccine or interferon do not significantly reduce CMV disease and CMV-associated mortality in solid organ transplant recipients |
| Propionyl-L-carnitine for intermittent claudication |
| Propofol and ketamine in combination versus ketamine or propofol alone for procedural sedation in children outside of the operating room |
| Propofol at night to improve sleep in the intensive care unit |
| Propofol for sedation during colonoscopy can lead to faster recovery after the procedure and higher patient satisfaction. |
| Propofol infusion for paediatric sedation |
| Propofol use for sedation in newborn babies undergoing procedures |
| Propofol versus thiopental sodium for the treatment of refractory status epilepticus (RSE) |
| Propranolol for migraine prophylaxis |
| Propylthiouracil for alcoholic liver disease |
| Prostacyclin and analogues for acute ischaemic stroke |
| Prostacyclin for pulmonary hypertension in adults |
| Prostacyclin in pulmonary arterial hypertension |
| Prostaglandin A for treating pre-eclampsia |
| Prostaglandin E1 analogues for chronic hepatitis B |
| Prostaglandin E1 for diabetic neuropathy |
| Prostaglandin E1 for keeping the duct open in heart conditions in the newborn |
| Prostaglandin E1 for preventing the progression of diabetic kidney disease |
| Prostaglandin E1 helps many men suffering from erectile dysfunction to have sexual intercourse |
| Prostaglandins for management of retained placenta |
| Prostaglandins for prelabour rupture of membranes at or near term |
| Prostaglandins for preventing postpartum haemorrhage |
| Prostaglandins to treat adults who have undergone liver transplantation |
| Prostaglandins versus oxytocin for prelabour rupture of membranes at or near term |
| Prostaglandins versus oxytocin for prelabour rupture of membranes at term |
| Prostanoids for intermittent claudication |
| Prostanoids for people with severely blocked arteries of the leg |
| Prostanoids in pulmonary hypertension of the newborn |
| Prostatic arterial embolization for treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia |
| Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia |
| Protease activity and its association with future healing of venous leg ulcers |
| Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus |
| Protease modulating dressings for treating diabetic foot ulcers |
| Protease-modulating matrix treatments for healing venous leg ulcers |
| Protective analgesia for postoperative pain following third molar surgery |
